0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Environment impacts the metabolic dependencies of Ras-driven non-small cell lung cancer

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          SUMMARY

          Cultured cells convert glucose to lactate and glutamine is the major source of tricarboxylic acid (TCA) cycle carbon, but whether the same metabolic phenotype is found in tumors is less studied. We infused mice with lung cancers with isotope-labeled glucose or glutamine and compared the fate of these nutrients in tumor and normal tissue. As expected, lung tumors exhibit increased lactate production from glucose. However, glutamine utilization by both lung tumors and normal lung was minimal, with lung tumors showing increased glucose contribution to the TCA cycle relative to normal lung tissue. Deletion of enzymes involved in glucose oxidation demonstrates that glucose carbon contribution to the TCA cycle is required for tumor formation. These data suggest that understanding nutrient utilization by tumors can predict metabolic dependencies of cancers in vivo. Furthermore, these data argue that the in vivo environment is an important determinant of the metabolic phenotype of cancer cells.

          Related collections

          Author and article information

          Journal
          101233170
          32527
          Cell Metab
          Cell Metab.
          Cell metabolism
          1550-4131
          1932-7420
          11 February 2016
          4 February 2016
          8 March 2016
          08 March 2017
          : 23
          : 3
          : 517-528
          Affiliations
          [1 ]Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
          [2 ]Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
          [3 ]Broad Institute of MIT and Harvard University, Cambridge, Massachusetts, USA
          [4 ]Division of Cardiovascular Medicine, Department of Medicine, The Brigham and Women’s Hospital, Boston, MA 02115, USA
          [5 ]Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
          [6 ]Elucidata Corporation, 161 Columbia St., Cambridge MA 02139
          [7 ]National Center for Advancing Translational Sciences, NIH, Bethesda, Maryland, USA
          [8 ]Dana-Farber Cancer Institute, Boston, Massachusetts, USA
          Author notes
          [* ]Correspondence: mvh@ 123456mit.edu
          Article
          PMC4785096 PMC4785096 4785096 nihpa758714
          10.1016/j.cmet.2016.01.007
          4785096
          26853747
          340591a2-1a2e-49bc-94e3-93395ce0d602
          History
          Categories
          Article

          Comments

          Comment on this article